Literature DB >> 25424171

The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.

Xing-Xing He1, Shu-Zhen Kuang, Jia-Zhi Liao, Chuan-Rui Xu, Ying Chang, Yu-Liang Wu, Jing Gong, De-An Tian, An-Yuan Guo, Ju-Sheng Lin.   

Abstract

UNLABELLED: Emerging evidence indicates that microRNAs (miRNAs) are often dysregulated and play a fundamental role in hepatocellular carcinoma (HCC). However, the mechanism underlying miRNA dysregulation is still elusive. In the present study, we adopted an integrated analysis strategy combining data from genome-wide methylated DNA immunoprecipitation chip and miRNA expression microarray to study the regulation of DNA methylation on miRNA expression in HCC. We first characterized 864 differentially methylated regions (DMRs) located in 236 miRNA regions between cancerous and normal hepatocytes in HCC. We observed that the occurrence of miRNA DNA hypomethylation was more common than its hypermethylation while miRNA DNA hypermethylation was usually found in CpG islands. Then through correlation analysis between miRNA methylation and expression data, we identified 10 dysregulated miRNAs under the potential regulation of DNA methylation in HCC. Five of them (miR-148a, miR-375, miR-195, miR-497 and miR-378) were in hypermethylation and down-regulation status, while another five (miR-106b, miR-25, miR-93, miR-23a and miR-27a) were in hypomethylation and up-regulation status in HCC. Bioinformatics analysis showed that miR-148a may form a negative feedback loop with its targets DNMT1 and DNMT3B and the expression of the miR-195/497 cluster may be affected not only by their hypermethylated promoter region but also by their hypermethylated transcription factors NEUROG2 and DDIT3.
CONCLUSION: our preliminary data and bioinformatics analysis suggest that DNA methylation plays an important and complex role in the regulation of miRNA expression in HCC, which may provide insights into the pathogenesis of HCC and thus may be used for diagnosis and intervention.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25424171     DOI: 10.1039/c4mb00563e

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  37 in total

1.  Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.

Authors:  A Mizrahi; A Barzilai; D Gur-Wahnon; I Z Ben-Dov; S Glassberg; T Meningher; E Elharar; M Masalha; J Jacob-Hirsch; H Tabibian-Keissar; I Barshack; J Roszik; R Leibowitz-Amit; Y Sidi; D Avni
Journal:  Oncogene       Date:  2017-09-18       Impact factor: 9.867

Review 2.  Mutual regulation of microRNAs and DNA methylation in human cancers.

Authors:  Sumei Wang; Wanyin Wu; Francois X Claret
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

3.  TAp63-Regulated miRNAs Suppress Cutaneous Squamous Cell Carcinoma through Inhibition of a Network of Cell-Cycle Genes.

Authors:  Andrew John Davis; Maksym Tsinkevich; Jason Rodencal; Hussein A Abbas; Xiao-Hua Su; Young-Jin Gi; Bin Fang; Kimal Rajapakshe; Cristian Coarfa; Preethi H Gunaratne; John M Koomen; Kenneth Y Tsai; Elsa R Flores
Journal:  Cancer Res       Date:  2020-03-10       Impact factor: 12.701

4.  Hypermethylation of microRNA-497-3p contributes to progression of thyroid cancer through activation of PAK1/β-catenin.

Authors:  Yuxia Fan; Xin Fan; Hao Yan; Zheng Liu; Xiaoming Wang; Qingling Yuan; Jie Xie; Xiubo Lu; Yang Yang
Journal:  Cell Biol Toxicol       Date:  2022-01-23       Impact factor: 6.691

5.  microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma.

Authors:  Lei Zhang; Zhaoxiang Yu; Yao Xian; Xiaobo Lin
Journal:  FEBS Open Bio       Date:  2016-02-01       Impact factor: 2.693

6.  SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497.

Authors:  Qianshan Ding; Ke He; Tao Luo; Yunchao Deng; Hanning Wang; Hao Liu; Jinqian Zhang; Kaiyun Chen; Jinfeng Xiao; Xiaopeng Duan; Rui Huang; Zhenglin Xia; Wenjie Zhou; Jinliang He; Honggang Yu; Xingyuan Jiao; Guoan Xiang
Journal:  Mol Ther       Date:  2016-01-12       Impact factor: 11.454

7.  MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.

Authors:  Alessandra Tessitore; Germana Cicciarelli; Filippo Del Vecchio; Agata Gaggiano; Daniela Verzella; Mariafausta Fischietti; Valentina Mastroiaco; Antonella Vetuschi; Roberta Sferra; Remo Barnabei; Daria Capece; Francesca Zazzeroni; Edoardo Alesse
Journal:  BMC Cancer       Date:  2016-01-05       Impact factor: 4.430

Review 8.  Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.

Authors:  Mohammad Reza Karimzadeh; Peyman Pourdavoud; Naeim Ehtesham; Mohaddese Qadbeigi; Masood Movahedi Asl; Behrang Alani; Meysam Mosallaei; Bahram Pakzad
Journal:  Cancer Gene Ther       Date:  2020-08-10       Impact factor: 5.987

9.  Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer.

Authors:  Martha D Gay; Anita Safronenka; Hong Cao; Felice H Liu; Zoe X Malchiodi; Robin D Tucker; Alexander Kroemer; Narayan Shivapurkar; Jill P Smith
Journal:  Cancer Prev Res (Phila)       Date:  2020-10-28

10.  Methylation Status of SP1 Sites within miR-23a-27a-24-2 Promoter Region Influences Laryngeal Cancer Cell Proliferation and Apoptosis.

Authors:  Ye Wang; Zhao-Xiong Zhang; Sheng Chen; Guang-Bin Qiu; Zhen-Ming Xu; Wei-Neng Fu
Journal:  Biomed Res Int       Date:  2016-03-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.